Mary Seau Founder & CEO of Mary CTE Foundation
I started this foundation in memory of my brother Junior Seau. It is my wish to inform and to educate the community regarding CTE. I have partnered with Boston University’s Dr. Ann McKee in the Early CTE Research Program. Our vision is to help provide an understanding on how CTE can impair and destroy.
The Concussion Legacy Foundation is dedicated to advancing the study, treatment and prevention of the effects of brain trauma in athletes and other at-risk groups. concussion foundation.org
Abilities Expo is about bringing necessary products and services together under one roof for the community of people with disabilities, their families, caregivers, seniors, and healthcare professionals. It's about introducing opportunities that can enrich your life. www.abilities.com
Elliott McKenzie is a U.S. Marine Corps Iraq War veteran turned R&B singer/songwriter. When he came home from Iraq, Elliott experienced severe PTSD, depression, and anxiety. So much so that he ended up homeless. After years of treatment, Elliott started using his abilities in music as a form of therapy for his issues and is now a successful recording artist and college graduate. His debut single entitled “Gunshots” is a powerful anthem about being a combat veteran with PTSD. His latest single called “Fight Back” is another inspiring song about fighting back against mental illness. His music has influenced and inspired people all across the world. Elliott’s debut album “Therapy Session” is set to release this year. To learn more about Elliott and support his music please visit www.elliottmckenzie.com
Suzanne Gordon is an American journalist and author who writes about healthcare delivery and health care systems and patient safety and nursing. ... She is author, co-author or editor of 18 books. She is currently working on a book about the
Bob Vincent is President of Reel Heroes Media in Dallas, Texas, and serves as the Communications Director for the Airpower Foundation. Bob founded the company in 2008 with a revolutionary online marketing product called VideoPilot360. Bob’s talents are rooted in his unique ability to create valuable relationships and produce high-quality productions. That skill has made him a trusted resource by some of the largest brands and entertainers across the United States, including Rascal Flatts, Gary Sinise, Tony Orlando, Lee Greenwood, Chef Robert Irvine, Billy Ray Cyrus, and Terry Fator, with accolades from corporate giants like Disney, American Airlines, DEKA Research & Development Corporation, MGM Resorts International, and Sears.
His compelling and sensitive video productions for the Airpower Foundation, Sky Ball, American Airlines Veterans Initiatives, Snowball Express, The American Fallen Soldiers Project, The Gary Sinise Foundation, and many other organizations, have earned him praise from military family members who benefit from those philanthropies. His videos are credited for helping motivate patriotic Americans to donate millions of dollars in donations to those organizations and inspiring others to volunteer their time to help. One particular video produced by Bob was recently responsible for assisting the Independence Corps Foundation, along with inventor, and DEKA Corp. CEO, Dean Kamen, to resume production of the iBOT mobility device, making the next generation of this amazing technology available to those who need it most. Bob and his company were also proudly featured in U.S. Veterans magazine.
Ritter Pharmaceuticals, develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. We are advancing human gut health research by exploring the metabolic capacity of the gut microbiota and translating the functionality of prebiotic-based therapeutics into applications intended to have a meaningful impact on a patient’s health. Our first novel microbiome modulator, RP-G28, is currently under development for the treatment of lactose intolerance. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby effectively adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. RP-G28 has the potential to become the first drug approved by the U.S. Food and Drug Administration (FDA), for the treatment of lactose intolerance.
Dr. Joseph Mosquera has over 30 years of experience caring for the Latino community as a general practitioner in Newark, NJ. Dr.Mosquera is a graduate of Rutgers Medical School (now UMDNJ). He studied Neurology at George Washington University Hospital and completed his residency and training in Internal Medicine at Hackensack University Medical Center. He then went on to graduate from the University of Arizona Medical School’s Program in Integrative Medicine in 2004. Dr. Mosquera is also a Harvard Medical School Fellowship graduate in Structural Acupuncture and Traditional Chinese Medicine, and is certified in Ericksonian Hypnotherapy and Psychotherapy.